Education

• PhD in Pharmacogenomics. Department of Pharmacology and Therapeutics, UAE University, UAE.
• American Board of Pharmacotherapy (BCPS) - Credential No.: 3153284. American Pharmacists Association, USA.
• MSc Clinical Pharmacy. College of Pharmacy, Al Ain University.
• MSc Clinical Pharmacy. School of Pharmacy, Queen's University Belfast, UK.
• Bachelor of Pharmacy. College of Pharmacy, Ajman University, UAE.
• DIP in IV compounding. Notting Hill College, UK.

Research Interests

My research interests are in the field of clinical pharmacy and pharmacogenomics, focusing on two main areas:

(1) Pharmacogenomics and Precision Medicine: capturing human genetic information to study individual responses to drugs and studying a specific drug response in patients based on the identification of their gene variants to make clinical decisions based on their genetic profile and communicating this to healthcare providers.

(2) Clinical Pharmacy: exploring the impact and role of clinical pharmacists in the implementation of healthcare processes and services and in the evaluation of the safety and efficacy of medicines to improve patient outcomes and the quality of services provided to patients, as well as overall healthcare outcomes.

Selected Publications

 

• Alomar, M.J., Al-Tabakha, M.M., Shahwan, M., Al-Khateeb, A., Palaian, S. and Al-Ahmad, M.M., 2026. Experimental evaluation of selected fish oil supplements available in the UAE market and factors associated with the extent of their oxidation. Asian Journal of Advanced Research and Reports, 20(1), pp.247–260.https://doi.org/10.9734/ajarr/2026/v20i11265
• Ebaid, N.F., Abdelkawy, K.S., Said, A.S.A., Al-Ahmad, M.M., Shehata, M.A., Salem, H.F. and Hussein, R.R.S., 2025. Is the neutrophil-to-lymphocyte ratio a predictive factor of pathological complete response in Egyptian breast cancer patients treated with neoadjuvant chemotherapy? Medicina (Kaunas), 61(2), 327. https://doi.org/10.3390/medicina61020327
• Mohamed, A.G., Badawy, H.F., Said, A.S.A., Al-Ahmad, M.M., Rabie, A.S.I., Salah, H., Massoud, R., Hussein, R.R.S., Khalil, D.M., Yousef, A. and Ibrahim, R.M., 2025. Additive value of pyridostigmine to silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia: a randomized controlled trial. Journal of Clinical Medicine, 14(3), 674. https://doi.org/10.3390/jcm14030674
• Al-Salman, R.S., Al-Ahmad, M.M. and Alameri, H., 2025. Trends in total antioxidant status and other biochemical parameters in type 2 diabetes mellitus: a case-control study. Current Diabetes Reviews. https://doi.org/10.2174/0115733998336940241219182916
• Mohamed, S., Palaian, S., Alomar, M. and Al-Ahmad, M.M., 2025. A national survey on community pharmacists’ perception, practice and perceived barriers towards pharmaceutical care services in the United Arab Emirates. Journal of Pharmaceutical Policy and Practice, 18(1), Article 2523936. https://doi.org/10.1080/20523211.2025.2523936
• Bader, N.A., Al-Ahmad, M.M., Al Naeem, W. and Amer, M.G., 2025. Efficacy of nefopam in postoperative pain management: a systematic review of opioid consumption. Journal of Applied Pharmaceutical Science, 15(5), pp.024–039. https://doi.org/10.7324/JAPS.2025.205927
• Said, H.K., Rabie, A.S.I., Said, A.S.A., Al-Ahmad, M.M., Hussein, R.R.S., Mady, M., El-Kalaawy, A.M., Hashem, K.S. and Ahmed, A.E., 2025. Naringin alleviates digoxin-induced nephrotoxicity via regulating Nrf2/HO-1 and PI3K/AKT/TGF-β cascades in rats’ renal tissues. Current Pharmaceutical Biotechnology, 26. https://doi.org/10.2174/0113892010340746250421065424
• Alqasrawi, M.N., Al-Mahayri, Z.N., Khasawneh, L.Q., AlBawa’neh, A.S., Dabaghie, L., Altoum, S.M., Hamza, D., Aburuz, S.A., Misra, V., Jamil, G., Ouda, H., Al-Bakshy, F., AlAhamad, K., Al-Ahmad, M.M., Al-Maskari, F., AlKaabi, J., Patrinos, G.P. and Ali, B.R., 2025. A multi-centre observational cohort study on pharmacogenomic predictors of rosuvastatin discontinuation in a multiethnic population. Frontiers in Pharmacology, 16, 1656520. https://doi.org/10.3389/fphar.2025.1656520

Teaching Courses

• MSc: Advance Pharmacotherapeutics (Endocrine and CNS Disorders)
• MSc: Advance Pharmacotherapeutics (Respiratory, GIT, Kidney Diseases and Liver Complications)
• MSc Clinical Pharmacy Training: Clerkship and Clinical Rotations Courses 
• BSc: Pharmacogenomics 
• BSc: Pharmacotherapy II (Cardiovascular Diseases)
• BSc: Pharmacotherapy III (Infectious Diseases)
• BSc Hospital Pharmacy Training: Advanced Pharmacy Practice Experience Courses (APPE 1-4) 
• BSc Community Pharmacy Training: Introductory Pharmacy Practice Experience Courses (IPPE 1-3)

 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all.

This person’s work contributes towards the following SDG(s):

 

Memberships

1. American Board of Pharmacotherapy (BCPS) - Credential No.: 3153284. American Pharmacists Association, USA. 2016.
2. Good Clinical Practice certificate – Certification No.: 2617772. National Institutes of Health (NIH) of Extramural Research Certifies. 2018